Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Thalassemia × Busulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 25 Myelodysplastic Syndromes 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Leukemia 14 Lymphoma, Non-Hodgkin 13 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Multiple Myeloma 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Hodgkin Disease 11 Lymphoma 10 Myeloproliferative Disorders 9 Neoplasms, Plasma Cell 8 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, Follicular 7 Leukemia, Myelomonocytic, Chronic 7 Leukemia, Myeloid, Accelerated Phase 7 Primary Myelofibrosis 6 Lymphoma, Mantle-Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia, Myelomonocytic, Juvenile 6 Leukemia, Myeloid, Chronic-Phase 6 Congenital Abnormalities 6 Blast Crisis 6 Myelodysplastic-Myeloproliferative Diseases 5 Lymphoma, Large-Cell, Immunoblastic 5 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Hematologic Neoplasms 5 Burkitt Lymphoma 5 Sezary Syndrome 4 Sarcoma 4

Interventions

fludarabine phosphate 2 Cyclophosphamide 2 fludarabine 1 Whole-Body Irradiation 1 Peripheral Blood Stem Cell Transplantation 1 Mesna 1 Busulfan 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡